SEC Form 4 · accession 0001179110-16-031866
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Capek
Officer — Executive Vice President
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Nov 16, 2016 | M | 22,000 | $24.3812 | A | 274,524 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $24.3812 | Nov 16, 2016 | M | 22,000 | D | Aug 1, 2010 | Jul 31, 2017 | Common shares | 22,000 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.